Maternal lymphocytotoxic antibodies and bilirubin levels in the postpartum offspring. 1977

G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz

HLA antigens are present on immature red cells (Harris & Zervas 1969), but disappear from their surface when they become mature and enter into the circulation (Silvestre et al. 1970). Nevertheless some remnants of HLA substance may survive this antigenic switch and possibly persist on adult red cells (Morton et al. 1969, 1971, Doughty et al. 1973). A shortened survival of HLA incompatible reticulocytes has been reported when they are transfused into recipients with circulating anti-HLA antibodies (Zervas et al. 1972). As to anti-HLA antibodies possibly reacting with erythrocytes in cases of fetomaternal immunization, Moulinier (1970) claimed that they would potentiate any hemolytic process in newborns of Rh-immunized women, but successive investigations failed to confirm this (Ahrons & Glavind-Kristensen 1971, Nymand 1975). Also, Nymand (1975) found no association between lymphocytotoxic antibodies in mothers and high bilirubin levels in the umbilical cord blood collected at delivery. On the contrary, when the onset of neonatal jaundice in the postpartum offspring was monitored, newborns of mothers with lymphocytotoxins appeared to become jaundiced more frequently than expected (Reekers et al. 1975). The present study has been undertaken to investigate the relationships between complement dependent lymphocytotoxins (CdL) in the mothers and the bilirubin levels in the newborns during the first days of life.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007567 Jaundice, Neonatal Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES. Icterus Gravis Neonatorum,Neonatal Jaundice,Physiological Neonatal Jaundice,Severe Jaundice in Neonate,Severe Jaundice in Newborn,Jaundice, Physiological Neonatal,Neonatal Jaundice, Physiological
D008233 Lymphotoxin-alpha A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR. TNF Superfamily, Member 1,TNF-beta,Tumor Necrosis Factor Ligand Superfamily Member 1,Tumor Necrosis Factor-beta,Lymphotoxin,Lymphotoxin-alpha3,Soluble Lymphotoxin-alpha,alpha-Lymphotoxin,Lymphotoxin alpha,Lymphotoxin alpha3,Lymphotoxin-alpha, Soluble,Soluble Lymphotoxin alpha,Tumor Necrosis Factor beta,alpha Lymphotoxin
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001789 Blood Group Antigens Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties. Blood Group,Blood Group Antigen,Blood Groups,Antigen, Blood Group,Antigens, Blood Group,Group Antigen, Blood,Group, Blood,Groups, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
September 1976, Obstetrics and gynecology,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
April 1980, Lancet (London, England),
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
January 1980, Progress in clinical immunology,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
January 1988, In vivo (Athens, Greece),
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
January 1978, Australian and New Zealand journal of medicine,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
October 1977, Archives for dermatological research = Archiv fur dermatologische Forschung,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
December 1983, Bulletin de la Societe de pathologie exotique et de ses filiales,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
April 1976, Lancet (London, England),
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
June 2020, Hormones and behavior,
G Carandina, and L DeRitis, and P Palazzi, and P L Mattiuz
January 2021, Evolution, medicine, and public health,
Copied contents to your clipboard!